JNJ Hits 64-Year Dividend Streak Mark as Stock Climbs 50%

Johnson & Johnson (JNJ) has extended its record of annual dividend increases to 64 consecutive years after raising its quarterly payout by 3.1%, from $1.30 to $1.34 per share in April.

This milestone is rare among US publicly traded companies, with only nine others having longer records of consecutive dividend growth.

The new quarterly rate translates to an annual dividend of $5.36 per share, providing investors with approximately $204 in dividend income per year for a $10,000 investment at the current share price of around $260.

While the forward dividend yield is relatively modest at 2.07%, it's not the primary appeal of the stock.

The combination of growth and income has been on display recently, with the stock rising 50% over the past 52 weeks and 26% so far in 2026, outperforming the S&P 500's gains of 21.6% over the past year and 13% in 2026.

Johnson & Johnson has made significant progress across its businesses, including winning approval for Icotyde, a new oral peptide treatment for plaque psoriasis, and developing Milvexian, an investigational anticoagulant that could reduce bleeding risk compared to existing therapies.